Table

Exscientia Business Update for Second Quarter and First Half 2022

Retrieved on: 
Wednesday, August 17, 2022 - 9:01pm
Software, Research, General Health, Pharmaceutical, Oncology, Medical Devices, Technology, Health Technology, Clinical Trials, Science, Biotechnology, Health, Multimedia, Precision medicine, Table, Drug discovery, Inflammation, Surface plasmon resonance, BID, UK Research and Innovation, Trust law, Technology, USD, Toxicity, IND, Achievement, MAD, Research, GBP, DevOps, Probability, BMS, British Empire Medal, GPCR, Wellcome Trust, SAD, ACS Medicinal Chemistry Letters, Company, International, CTA, Federal Reserve Bank, Innovation, Partnership, MBE, Economics, Â, Biology, BST, Cheminformatics, Most, Journal, ID, Immunity, Federal Reserve Bank of New York, Journal of Chemical Information and Modeling, Pharmacokinetics, Pharmaceutical industry, Cryptocurrency, Vaccine, Medical imaging, Medical device, Online gambling, Bayer, Sanofi

View the full release here: https://www.businesswire.com/news/home/20220817005681/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220817005681/en/
    Recent developments in the Companys pipeline, collaborations, and operations, as well as financial results for the second quarter and first half 2022, are summarised below.
  • In addition, Exscientia will host a conference call Thursday, August 18 at 1:30 p.m. BST / 8:30 a.m.
  • In the first half of 2022, we delivered on major new and existing collaborations, advanced our pipeline programmes, and marked the 10-year anniversary of Exscientias founding.
  • A replay will be available for 90 days under "Events and Presentations in the Investors and Media section of the Exscientia website .

FCW and Carahsoft Host GovForward FedRAMP Summit on August 24, 2022

Retrieved on: 
Wednesday, August 17, 2022 - 6:20pm
Federal, Trust (social science), Micro Focus, Table, Public sector, CIP, CISM, Policy, Defense Information Systems Agency, FedRAMP, Environment, SAP, CISO, CISA, FCW, Solution, Zoom, Risk management, Management, Technology

FCW and Carahsoft Technology Corp., The Trusted Government IT Solutions Provider, will be hosting the annual GovForward FedRAMP Summit on Wednesday, August 24 in Washington D.C.

Key Points: 
  • FCW and Carahsoft Technology Corp., The Trusted Government IT Solutions Provider, will be hosting the annual GovForward FedRAMP Summit on Wednesday, August 24 in Washington D.C.
  • The second in the 2022 series of Carahsoft GovForward events focusing on FedRAMP, will be held in-person and virtually.
  • The summit will explore the new FedRAMP policy developments, how the changing threat environment challenges agencies with limited people and budgetary resources and lessons learned from the log4j vulnerability.
  • Attendees are encouraged to learn more about each of these solution providers by visiting their tables at the onsite event to access relevant resources, chat with company representatives, or learn about FedRAMP solutions through Carahsofts reseller partners.

Radiant Exhibits and Presents Smart Glass Measurement Solutions for Emerging Sunroof Technologies at Vehicle Displays & Interfaces

Retrieved on: 
Wednesday, August 17, 2022 - 5:15pm
Electronics, Glass, Table, Exhibition, Industry, Konica Minolta, Technology, Growth, Sun photometer, Software, Original equipment manufacturer, HUD, Method, Hud, International, Society, Scholz, Lighting, SID, Sacramento Sessions/5 of 3, Light-emitting diode, Color, Quality control, Automotive industry, Interface, Prometric, Solution, Device file, Efficiency, Ceramic, Online shopping, Radiant

REDMOND, Wash., Aug. 17, 2022 /PRNewswire-PRWeb/ -- Radiant Vision Systems, a leading provider of test and measurement solutions for automotive displays, announces that it will exhibit and lead a technical session at the SID (Society for Information Display) 29th Annual Vehicle Displays & Interfaces Symposium & Expo. The event takes place at a new location at the Sheraton Detroit Novi Hotel on September 27 and 28, 2022. Radiant will exhibit solutions for evaluating the visual quality of head-up displays (HUD) and other automotive display integrations from tables 601 & 603 in the exhibit hall and will present a paper during Session 5: Display Metrology on Wednesday, September 28, beginning at 10:40 A.M. local time.

Key Points: 
  • Vehicle Displays & Interfaces has provided the leading forum for automotive display technology for nearly 30 years.
  • Topics of this year's event include automotive market trends, touch interfaces, HUDs, component & substrate innovations, lighting, and display measurement.
  • However, the size of sunroof panels, intricacies of their etched patterns, and glass curvature make this emerging inspection application difficult to address using traditional display measurement technologies.
  • Throughout the event, Radiant will also demonstrate its solutions for automotive display testing from tables 601 & 603 as part of the Vehicle Displays & Interfaces exhibition.

ARHAUS PARTNERS WITH THE SURF LODGE TO OUTFIT THE MONTAUK PROPERTY'S BEACHFRONT

Retrieved on: 
Wednesday, August 17, 2022 - 2:02pm
Summer of Love, Multimedia, Love, Farmer, Table, CEO, Fort Pond Bay, E-commerce, Family, Beauty, ARHS, Creative director, Canyon Collective Factory Team, Partnership, NASDAQ, Community, Music, Culture, Friends, Collection, Omnichannel, Hotel, Entertainment, Tourism, Arhaus

BOSTON HEIGHTS, Ohio, Aug. 17, 2022 /PRNewswire/ -- Arhaus (NASDAQ: ARHS), a leader in artisan-crafted and responsibly sourced home furnishings, and The Surf Lodge, Montauk's sought-after destination for locals and visitors alike, collaborated on an exterior refresh, outfitting the property's Fort Pond beachfront with Arhaus furnishings from the brand's latest Outdoor Collection. The complete assortment of Arhaus pieces showcased at The Surf Lodge is available at Arhaus.com/TheSurfLodge. 

Key Points: 
  • The complete assortment of Arhaus pieces showcased at The Surf Lodge is available at Arhaus.com/TheSurfLodge .
  • "Community and timeless design are what inspire us at Arhaus, and we are thrilled to celebrate these values through our partnership with The Surf Lodge," said John Reed, Arhaus Co-Founder and CEO.
  • Arhaus' one-of-a-kind assortment stretches across The Surf Lodge's beach and adjacent private dining deck, thoughtfully situated for comfort, versatility, and good times.
  • "I fell in love with Arhaus for its artisan craftsmanship," said Jayma Cardoso, Founder and Creative Director, The Surf Lodge.

Global Oxygen Cylinder and Concentrator Market Predicted to Gather $6,706.7 Million by 2028, Growing at CAGR of 5.1% from 2021 to 2028 [176-Pages] | Issued by Research Dive

Retrieved on: 
Wednesday, August 17, 2022 - 2:01pm
TOC, 2017 Gorakhpur hospital deaths, Center for Urban and Regional Analysis, Oxygen, Medication, Asthma, NEW, Growth, Gas, Incidence, Chronic obstructive pulmonary disease, Patient, Table, COVID-19, Mark (given name), Portable, COPD, Accident, CAGR, Infection, Respiratory system, Chronic Respiratory Disease, Aerospace, Health care, Health insurance, Poultry, Propane

NEW YORK, Aug. 17, 2022 /PRNewswire/ -- Research Dive has added a new report to its offering titled, "Oxygen Cylinder and Concentrator Market by Product (Portable and Fixed), End-user (Healthcare, Pharmaceutical & biotechnology, Manufacturing, and Aerospace & automotive), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2021–2028".

Key Points: 
  • As per the report, the global oxygen cylinder and concentrator market is predicted to grow at a noteworthy CAGR of 5.1% in the 2021-2028 timeframe, thereby gathering $6,706.7 million by 2028.
  • This surge in the number of cases of respiratory ailments is expected to push the oxygen cylinder and concentrator market forward.
  • Restraints:However, the high investment cost is expected to hamper the growth of the oxygen cylinder and concentrator market.
  • By regional analysis, the oxygen cylinder and concentrator market in the Asia-Pacific region is expected to be the most lucrative and gather $1,985.2 million by 2028.

Global Oxygen Cylinder and Concentrator Market Predicted to Gather $6,706.7 Million by 2028, Growing at CAGR of 5.1% from 2021 to 2028 [176-Pages] | Issued by Research Dive

Retrieved on: 
Wednesday, August 17, 2022 - 2:01pm
TOC, 2017 Gorakhpur hospital deaths, Center for Urban and Regional Analysis, Oxygen, Medication, Asthma, NEW, Growth, Gas, Incidence, Chronic obstructive pulmonary disease, Patient, Table, COVID-19, Mark (given name), Portable, COPD, Accident, CAGR, Infection, Respiratory system, Chronic Respiratory Disease, Aerospace, Health care, Health insurance, Poultry, Propane

NEW YORK, Aug. 17, 2022 /PRNewswire/ -- Research Dive has added a new report to its offering titled, "Oxygen Cylinder and Concentrator Market by Product (Portable and Fixed), End-user (Healthcare, Pharmaceutical & biotechnology, Manufacturing, and Aerospace & automotive), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2021–2028".

Key Points: 
  • As per the report, the global oxygen cylinder and concentrator market is predicted to grow at a noteworthy CAGR of 5.1% in the 2021-2028 timeframe, thereby gathering $6,706.7 million by 2028.
  • This surge in the number of cases of respiratory ailments is expected to push the oxygen cylinder and concentrator market forward.
  • Restraints:However, the high investment cost is expected to hamper the growth of the oxygen cylinder and concentrator market.
  • By regional analysis, the oxygen cylinder and concentrator market in the Asia-Pacific region is expected to be the most lucrative and gather $1,985.2 million by 2028.

Sanfilippo Syndrome Epidemiology Forecast Report 2019-2022 & 2032 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 17, 2022 - 1:56pm
Health, Biotechnology, Table, United Kingdom, Disease, SME, Diagnosis, Classification, Sanfilippo syndrome, Epidemiology, Gaps, Lists of people executed in the United States, Vaccine, Dentistry, Pharmaceutical industry, Renewable energy

The "Sanfilippo Syndrome - Epidemiology Forecast to 2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Sanfilippo Syndrome - Epidemiology Forecast to 2032" report has been added to ResearchAndMarkets.com's offering.
  • This "Sanfilippo Syndrome - Epidemiology Forecast to 2032" report delivers an in-depth understanding of the disease, historical and forecasted Sanfilippo Syndrome epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
  • The Sanfilippo Syndrome epidemiology covered in the report provides historical as well as forecasted Sanfilippo Syndrome epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.
  • The Sanfilippo Syndrome report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
    The Sanfilippo Syndrome Epidemiology Report and Model provide an overview of the global trends of Sanfilippo Syndrome in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
    The report provides insight into the historical and forecasted patient pool of Sanfilippo Syndrome in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan

Febrile Neutropenia Epidemiology Forecast/Analysis Report 2019-2022 & 2032 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 17, 2022 - 1:39pm
Health, Biotechnology, Table, United Kingdom, Disease, SME, Diagnosis, Classification, Febrile neutropenia, Epidemiology, Lists of people executed in the United States, Vaccine, Renewable energy, Dentistry

This "Febrile Neutropenia - Epidemiology Forecast to 2032" report delivers an in-depth understanding of the disease, historical and forecasted Febrile Neutropenia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Key Points: 
  • This "Febrile Neutropenia - Epidemiology Forecast to 2032" report delivers an in-depth understanding of the disease, historical and forecasted Febrile Neutropenia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
  • The Febrile Neutropenia epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032.
  • The Febrile Neutropenia epidemiology covered in the report provides historical as well as forecasted Febrile Neutropenia epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.
  • The Febrile Neutropenia report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
    The Febrile Neutropenia Epidemiology Report and Model provide an overview of the global trends of Febrile Neutropenia in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
    The report provides insight into the historical and forecasted patient pool of Febrile Neutropenia in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan

Systemic Mastocytosis Epidemiology Forecast Report 2019-2022 & 2032 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 17, 2022 - 1:26pm
Health, Pharmaceutical, Mastocytosis, Table, United Kingdom, Disease, SME, Diagnosis, Classification, Epidemiology, Lists of people executed in the United States, Vaccine, Dentistry, Renewable energy

The "Systemic Mastocytosis - Epidemiology Forecast to 2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Systemic Mastocytosis - Epidemiology Forecast to 2032" report has been added to ResearchAndMarkets.com's offering.
  • This "Systemic Mastocytosis - Epidemiology Forecast to 2032" report delivers an in-depth understanding of the disease, historical and forecasted Systemic Mastocytosis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
  • The Systemic Mastocytosis epidemiology covered in the report provides historical as well as forecasted Systemic Mastocytosis epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.
  • The Systemic Mastocytosis report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
    The Systemic Mastocytosis Epidemiology Report and Model provide an overview of the global trends of Systemic Mastocytosis in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
    The report provides insight into the historical and forecasted patient pool of Systemic Mastocytosis in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan

OMNI-LITE INDUSTRIES REPORTS SECOND QUARTER FISCAL 2022 RESULTS AND ANNOUNCES CONFERENCE CALL FOR INVESTORS TO BE HELD ON AUGUST 18, 2022 AT 1PM EST

Retrieved on: 
Wednesday, August 17, 2022 - 12:00pm
Omni, Risk, Table, Legislation, Sale, TSX, TSX Venture Exchange, Analysis, Adjustment, Public expenditure, Review, EBITDA, Company, Contract, Depreciation, Tax, IFRS, News, Second, SEDAR, Security (finance)

Free Cash Flow is a non-IFRS financial measure defined as cash flow from operations minus capital expenditures.

Key Points: 
  • Free Cash Flow is a non-IFRS financial measure defined as cash flow from operations minus capital expenditures.
  • Adjusted Free Cash Flow is a non-IFRS financial measure defined as Free Cash Flow excluding, if any, gains (losses) on sale of assets and non-recurring items.
  • The non-IFRS financial measures as used herein may not be comparable to similarly titled measures reported by other companies.
  • Omni-Lite will host a conference call for investors on Thursday August 18, 2022, beginning at 1:00 P.M. Eastern Time to discuss the second quarter of fiscal 2022 results and review of its business and operations.